In conclusion, emerging evidence highlight the interaction of hENT-1 with tumor stroma and mechanical signaling, yet more evidence has to be obtained to have potential new targets to overcome pancreatic cancer progression and chemoresistance (Figure 4). This evidence concerns the gene SLC29A1 and familial pancreatic carcinoma.